L. reuteri JMR-01 adjuvant ¹²C⁶⁺ irradiation exerts anti-colon carcinoma effects by modulating the gut microbiota in mice

References

• Aindelis G, Tiptiri-Kourpeti A, Lampri E, Spyridopoulou K, Lamprianidou E, Kotsianidis I, Ypsilantis P, Pappa A, Chlichlia K. 2020. Immune responses raised in an experimental colon carcinoma model following oral administration of Lactobacillus casei. Cancers (Basel). 12(2):368.
   Google Scholar
• Alexander JL, Wilson ID, Teare J, Marchesi JR, Nicholson JK, Kinross JM. 2017. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol. 14(6):356–365.
   PubMed Web of Science ®Google Scholar
• Asadollahi P, Ghanavati R, Rohani M, Razavi S, Esghaei M, Talebi M. 2020. Anti-cancer effects of Bifidobacterium species in colon cancer cells and a mouse model of carcinogenesis. PLOS One. 15:e0232930.
   PubMedGoogle Scholar
• Badgeley A, Anwar H, Modi K, Murphy P, Lakshmikuttyamma A. 2021. Effect of probiotics and gut microbiota on anti-cancer drugs: mechanistic perspectives. Biochim Biophys Acta Rev Cancer. 1875(1):188494.
   PubMed Web of Science ®Google Scholar
• Chandel D, Sharma M, Chawla V, Sachdeva N, Shukla G. 2019. Isolation, characterization and identification of antigenotoxic and anticancerous indigenous probiotics and their prophylactic potential in experimental colon carcinogenesis. Sci Rep. 9(1):14769.
   PubMedGoogle Scholar
• Chen D, Jin D, Huang S, Wu J, Xu M, Liu T, Dong W, Liu X, Wang S, Zhong W, et al. 2020. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Lett. 469:456–467.
   PubMed Web of Science ®Google Scholar
• Chung Y, Ryu Y, An BC, Yoon Y-S, Choi O, Kim TY, Yoon J, Ahn JY, Park HJ, Kwon S-K, et al. 2021. A synthetic probiotic engineered for colorectal cancer therapy modulates gut microbiota. Microbiome. 9(1):122.
   PubMed Web of Science ®Google Scholar
• Cross ML, Ganner A, Teilab D, Fray LM. 2004. Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria. FEMS Immunol Med Microbiol. 42(2):173–180.
   PubMedGoogle Scholar
• Drago L. 2019. Probiotics and colon cancer. Microorganisms. 7:66.
   PubMed Web of Science ®Google Scholar
• Eslami M, Yousefi B, Kokhaei P, Hemati M, Nejad ZR, Arabkari V, Namdar A. 2019. Importance of probiotics in the prevention and treatment of colorectal cancer. J Cell Physiol. 234(10):17127–17143.
   PubMed Web of Science ®Google Scholar
• Foo NP, Ou Yang H, Chiu HH, Chan HY, Liao CC, Yu CK, Wang YJ. 2011. Probiotics prevent the development of 1,2-dimethylhydrazine (DMH)-induced colonic tumorigenesis through suppressed colonic mucosa cellular proliferation and increased stimulation of macrophages. J Agric Food Chem. 59(24):13337–13345.
   PubMed Web of Science ®Google Scholar
• Garcia-Mantrana I, Selma-Royo M, Alcantara C, Collado MC. 2018. Shifts on gut microbiota associated to Mediterranean diet adherence and specific dietary intakes on general adult population. Front Microbiol. 9:890.
   PubMed Web of Science ®Google Scholar
• Ghanavati R, Akbari A, Mohammadi F, Asadollahi P, Javadi A, Talebi M, Rohani M. 2020. Lactobacillus species inhibitory effect on colorectal cancer progression through modulating the Wnt/β-catenin signaling pathway. Mol Cell Biochem. 470(1–2):1–13.
   PubMed Web of Science ®Google Scholar
• Ghanavati R, Mohammadi F, Javadi A, Shahosseini Z, Talebi M, Rohani M. 2020. The effects of a mixture of Lactobacillus species on colorectal tumor cells activity through modulation of Hes1 pathway. PharmaNutrition. 13:100207.
   Web of Science ®Google Scholar
• Goetze K, Scholz M, Taucher-Scholz G, Mueller-Klieser W. 2007. The impact of conventional and heavy ion irradiation on tumor cell migration in vitro. Int J Radiat Biol. 83(11–12):889–896.
   PubMed Web of Science ®Google Scholar
• Gosai V, Ambalam P, Raman M, Kothari CR, Kothari RK, Vyas BR, Sheth NR. 2011. Protective effect of Lactobacillus rhamnosus 231 against N-methyl-N′-nitro-N-nitrosoguanidine in animal model. Gut Microbes. 2(6):319–325.
   PubMed Web of Science ®Google Scholar
• Han S, Pan Y, Yang X, Da M, Wei Q, Gao Y, Qi Q, Ru L. 2019. Intestinal microorganisms involved in colorectal cancer complicated with dyslipidosis. Cancer Biol Ther. 20(1):81–89.
   PubMed Web of Science ®Google Scholar
• Hold GL. 2016. Gastrointestinal microbiota and colon cancer. Dig Dis. 34(3):244–250.
   PubMed Web of Science ®Google Scholar
• Kahouli I, Malhotra M, Alaouijamali M, Prakash S. 2015. In-vitro characterization of the anti-cancer activity of the probiotic bacterium Lactobacillus fermentum NCIMB 5221 and potential against colorectal cancer. J Cancer Sci Ther. 7:224–235.
   Google Scholar
• Kwong TNY, Wang X, Nakatsu G, Chow TC, Tipoe T, Dai RZW, Tsoi KKK, Wong MCS, Tse G, Chan MTV, et al. 2018. Association between bacteremia from specific microbes and subsequent diagnosis of colorectal cancer. Gastroenterology. 155(2):383–390.e388.
   PubMed Web of Science ®Google Scholar
• Lee J, d‘Aigle J, Atadja L, Quaicoe V, Honarpisheh P, Ganesh BP, Hassan A, Graf J, Petrosino J, Putluri N, et al. 2020. Gut microbiota-derived short-chain fatty acids promote poststroke recovery in aged mice. Circ Res. 127(4):453–465.
   PubMed Web of Science ®Google Scholar
• Lee SH, Yoon JM, Kim YH, Jeong DG, Park S, Kang DJ. 2016. Therapeutic effect of tyndallized Lactobacillus rhamnosus IDCC 3201 on atopic dermatitis mediated by down-regulation of immunoglobulin E in NC/Nga mice. Microbiol Immunol. 60(7):468–476.
   PubMed Web of Science ®Google Scholar
• Lee SM, Lee WK. 2001. Effects of lactic acid bacteria on intestinal microbial enzyme activity and composition in rats treated with azoxymethane. J Microbiol. 39:154–161.
   Web of Science ®Google Scholar
• Lührs H, Gerke T, Müller JG, Melcher R, Schauber J, Boxberge F, Scheppach W, Menzel T. 2002. Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol. 37(4):458–466.
   PubMed Web of Science ®Google Scholar
• Mager LF, Burkhard R, Pett N, Cooke NCA, Brown K, Ramay H, Paik S, Stagg J, Groves RA, Gallo M, et al. 2020. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science. 369(6510):1481–1489.
   PubMed Web of Science ®Google Scholar
• Malouff TD, Mahajan A, Mutter RW, Krishnan S, Hoppe BS, Beltran C, Trifiletti DM, Vallow LA. 2020. Carbon ion radiation therapy in breast cancer: a new frontier. Breast Cancer Res Treat. 181(2):291–296.
   PubMed Web of Science ®Google Scholar
• Oh NS, Lee JY, Kim YT, Kim SH, Lee JH. 2020. Cancer-protective effect of a synbiotic combination between Lactobacillus gasseri 505 and a Cudrania tricuspidata leaf extract on colitis-associated colorectal cancer. Gut Microbes. 12(1):1785803.
   PubMed Web of Science ®Google Scholar
• Osterlund P, Ruotsalainen T, Korpela R, Saxelin M, Ollus A, Valta P, Kouri M, Elomaa I, Joensuu H. 2007. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer. 97(8):1028–1034.
   PubMed Web of Science ®Google Scholar
• Piqué N, Berlanga M, Miñana-Galbis D. 2019. Health benefits of heat-killed (tyndallized) probiotics: an overview. Int J Mol Sci. 20:2534.
   PubMed Web of Science ®Google Scholar
• Rackwitz T, Debus J. 2019. Clinical applications of proton and carbon ion therapy. Semin Oncol. 46(3):226–232.
   PubMed Web of Science ®Google Scholar
• Reddivari L, Veeramachaneni DNR, Walters WA, Lozupone C, Palmer J, Hewage MKK, Bhatnagar R, Amir A, Kennett MJ, Knight R, et al. 2017. Perinatal bisphenol A exposure induces chronic inflammation in rabbit offspring via modulation of gut bacteria and their metabolites. mSystems. 2(5):e00093-17.
   PubMed Web of Science ®Google Scholar
• Rivière A, Selak M, Lantin D, Leroy F, De Vuyst L. 2016. Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol. 7:979.
   PubMed Web of Science ®Google Scholar
• Rooks MG, Garrett WS. 2016. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 16(6):341–352.
   PubMed Web of Science ®Google Scholar
• Sadeghi-Aliabadi H, Mohammadi F, Fazeli H, Mirlohi M. 2014. Effects of Lactobacillus plantarum A7 with probiotic potential on colon cancer and normal cells proliferation in comparison with a commercial strain. Iran J Basic Med Sci. 17(10):815–819.
   PubMed Web of Science ®Google Scholar
• Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B, Alegre ML. 2015. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 350:1084–1089.
   PubMed Web of Science ®Google Scholar
• Song M, Chan AT, Sun J. 2020. Influence of the gut microbiome, diet, and environment on risk of colorectal cancer. Gastroenterology. 158(2):322–340.
   PubMed Web of Science ®Google Scholar
• Suit H, DeLaney T, Goldberg S, Paganetti H, Clasie B, Gerweck L, Niemierko A, Hall E, Flanz J, Hallman J, et al. 2010. Proton vs carbon ion beams in the definitive radiation treatment of cancer patients. Radiother Oncol. 95(1):3–22.
   PubMed Web of Science ®Google Scholar
• Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. 2014. The role of short-chain fatty acids in health and disease. Adv Immunol. 121:91–119.
   PubMed Web of Science ®Google Scholar
• Tao J, Li S, Gan R-Y, Zhao C-N, Meng X, Li H-B. 2020. Targeting gut microbiota with dietary components on cancer: effects and potential mechanisms of action. Crit Rev Food Sci Nutr. 60(6):1025–1037.
   PubMed Web of Science ®Google Scholar
• Taverniti V, Guglielmetti S. 2011. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr. 6(3):261–274.
   PubMed Web of Science ®Google Scholar
• Tiptiri-Kourpeti A, Spyridopoulou K, Santarmaki V, Aindelis G, Tompoulidou E, Lamprianidou EE, Saxami G, Ypsilantis P, Lampri ES, Simopoulos C, et al. 2016. Lactobacillus casei Exerts anti-proliferative effects accompanied by apoptotic cell death and up-regulation of TRAIL in colon carcinoma cells. PLOS One. 11(2):e0147960.
   PubMed Web of Science ®Google Scholar
• Tuo Y, Zhang L, Han X, Du M, Zhang Y, Yi H, Zhang W, Jiao Y. 2011. In vitro assessment of immunomodulating activity of the two Lactobacillus strains isolated from traditional fermented milk. World J Microb Biot. 27:505–511.
   Web of Science ®Google Scholar
• Valeur N, Engel P, Carbajal N, Connolly E, Ladefoged K. 2004. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol. 70(2):1176–1181.
   PubMed Web of Science ®Google Scholar
• van der Beek CM, Dejong CHC, Troost FJ, Masclee AAM, Lenaerts K. 2017. Role of short-chain fatty acids in colonic inflammation, carcinogenesis, and mucosal protection and healing. Nutr Rev. 75(4):286–305.
   PubMed Web of Science ®Google Scholar
• Wang CS-E, Li W-B, Wang H-Y, Ma Y-M, Zhao X-H, Yang H, Qian J-M, Li J-N. 2018. VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice. World J Gastroenterol. 24:4254–4262.
   PubMed Web of Science ®Google Scholar
• Wang G, Zhu L, Yu B, Chen K, Liu B, Liu J, Qin G, Liu C, Liu H, Chen K. 2016. Exopolysaccharide from Trichoderma pseudokoningii induces macrophage activation. Carbohydr Polym. 149:112–120.
   PubMed Web of Science ®Google Scholar
• Wang J, Wu T, Fang X, Min W, Yang Z. 2018. Characterization and immunomodulatory activity of an exopolysaccharide produced by Lactobacillus plantarum JLK0142 isolated from fermented dairy tofu. Int J Biol Macromol. 115:985–993.
   PubMed Web of Science ®Google Scholar
• Wang K, Xu X, Maimaiti A, Hao M, Sang X, Shan Q, Wu X, Cao G. 2021. Gut microbiota disorder caused by diterpenoids extracted from Euphorbia pekinensis aggravates intestinal mucosal damage. Pharmacol Res Perspect. 9(5):e00765.
   PubMed Web of Science ®Google Scholar
• Wei H, Xu Y, Cheng B, Xiong Y. 2007. Synergistic effects of Lactobacillus rhamnosus ZDY114 and bovine colostrums on the immunological function of mouse in vivo and in vitro. Appl Microbiol Biotechnol. 75(2):427–434.
   PubMed Web of Science ®Google Scholar
• Winkler P, Ghadimi D, Schrezenmeir J, Kraehenbuhl JP. 2007. Molecular and cellular basis of microflora–host interactions. J Nutr. 137(3 Suppl. 2):756s–772s.
   PubMed Web of Science ®Google Scholar
• Wu C. 2018. Systemic therapy for colon cancer. Surg Oncol Clin N Am. 27(2):235–242.
   PubMed Web of Science ®Google Scholar
• Xu F, Li Q, Wang S, Bai J, Dong M, Xiao G, Wang J. 2021. Lactobacillus casei JY300-8 generated by 12C6+ beams mutagenesis inhibits tumor progression by modulating the gut microbiota in mice. J Funct Foods. 87:104779.
   Web of Science ®Google Scholar
• Yamada S, Takiyama H, Isozaki Y, Shinoto M, Makishima H, Yamamoto N, Tsuji H. 2021. Carbon-ion radiotherapy for colorectal cancer. J Anus Rectum Colon. 5(2):113–120.
   PubMed Web of Science ®Google Scholar
• Yue Y, Ye K, Lu J, Wang X, Zhang S, Liu L, Yang B, Nassar K, Xu X, Pang X, et al. 2020. Probiotic strain Lactobacillus plantarum YYC-3 prevents colon cancer in mice by regulating the tumour microenvironment. Biomed Pharmacother. 127:110159.
   PubMed Web of Science ®Google Scholar
• Yusuf F, Adewiah S, Fatchiyah F. 2018. The level short chain fatty acids and HSP 70 in colorectal cancer and non-colorectal cancer. Acta Inform Med. 26(3):160–163.
   PubMedGoogle Scholar
• Zahran WE, Elsonbaty SM, Moawed FSM. 2017. Lactobacillus rhamnosus ATCC 7469 exopolysaccharides synergizes with low level ionizing radiation to modulate signaling molecular targets in colorectal carcinogenesis in rats. Biomed Pharmacother. 92:384–393.
   PubMed Web of Science ®Google Scholar
• Zheng D-W, Li R-Q, An J-X, Xie T-Q, Han Z-Y, Xu R, Fang Y, Zhang X-Z. 2020. Prebiotics-encapsulated probiotic spores regulate gut microbiota and suppress colon cancer. Adv Mater. 32(45):e2004529.
   PubMed Web of Science ®Google Scholar